Increasing demand for estrogen therapy coupled with a growing awareness and interest in the menopause market have led to supply disruptions with the estrogen patch. As women across the country ...

The Food and Drug Administration removed the black box warning from hormone replacement therapies late last year, and recently, the most insured type, the estrogen patch, has been in short supply amid ...

Menopause is not a time to stress. But we understand that the recent shortage of hormone replacement therapy (HRT) patches has women concerned. Luckily, one of the nation's top menopause experts, ...

A session at the recent Nurse Practitioners in Women's Health annual conference focused on vulvovaginal changes that occur during menopause, the effects of atrophic vaginitis on postmenopausal women, ...

The vaginal contraceptive ring represents one of the more recent innovations in hormonal birth control, offering a unique delivery system that combines convenience with effectiveness. Unlike daily ...

Choice of therapy is based on patient needs and preferences. Some patients find dosing of the cream confusing. Active estrogen cream dosing is specified in milligrams, the dose of base cream is in ...

Vaginal atrophy is a condition that can negatively impact the quality of life of many postmenopausal women. Local exogenous estrogen therapy can effectively alter the anatomic and pathophysiologic ...

Femring, a prescription vaginal ring uniquely designed to deliver continuous systemic estrogen therapy through a convenient, long-acting vaginal ring replaced every 90 days. Femring is designed to ...